Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

Silvio Danese, Severine Vermeire, Geert D'Haens, Julian Panés, Axel Dignass, Fernando Magro, Maciej Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Ivana Bravata, Frederic Lavie, Marco Daperno, Milan Lukáš, Alessandro Armuzzi, Mark Löwenberg, Daniel R Gaya, Laurent Peyrin-Biroulet, Rodolfo Rocca, Susana Lopes, Flavio Caprioli, Sandro Ardizzone, Ana Echarri Piudo, Paolo Gionchetti, Xavier Roblin, Ursula Seidler, David Andersson, Kamal Patel, Pierre Desreumaux, Simone Saibeni, Gustav From, Miroslav Fedurco, Milos Gregus, Yoram Bouhnik, Andreas Luegering, Rocco Cosintino, Ivan Bunganic, Jaime Ramos, Mariam Aguas Peris, Olivier Dewit, Mariabeatrice Principi, Emma Wesley, Paula Lago, Stephane Nancey, María Dolores Martín Arranz, Pieter Hindryckx, Ambrogio Orlando, Andrea Geccherle, Maria Laura Annunziata, Bu'hussain Hayee, Jozef Balaz, Francisco Portela, Cyrielle Gilletta, Torsten Kucharzik, Miguel Mínguez, Javier Pérez Gisbert, Ana Gutiérrez Casbas, Edouard Louis, Marco Marino, Gareth Parkes, Fraser Cummings, Bindia Jharap, Jens Kjeldsen, Luís Correia, Paula Ministro, Matthias Ebert, Erik Hertervig, Dirk Staessen, Joris Dutré, Arnaud Colard, Graham Morrison, Henning Glerup, Jens Frederik Dahlerup, Frank Wolfhagen, Marian Batovsky, Martin Molnar, Barbora Kadleckova, Paulo Caldeira, David Laharie, Xavier Hebuterne, Bruno Bonaz, Matthieu Allez, Andreas Fischer, Joaquín Ernesto Hinojosa Del Val, Miriam Mañosa Ciria, Jose Manuel Herrera Justiniano, Charlotte Soderman, Rajiv Chandy, Craig Mowat, Peter Irving, Jan Fallingborg, Jan Matous, Tomas Douda, Romain Altwegg, Jose Manuel Benitez, María Teresa Arroyo Villarino, Jordi Guardiola Capón, Daniel Ginard Vicenc, Pieter Dewint, Sven Almer, Sebastien Kindt

doi:10.1016/s2468-1253(21)00474-x

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

DOI Web Site Web Site 被引用文献1件

Silvio Danese
Severine Vermeire
Geert D'Haens
Julian Panés
Axel Dignass
Fernando Magro
Maciej Nazar
Manuela Le Bars
Marjolein Lahaye
Lioudmila Ni
Ivana Bravata
Frederic Lavie
Marco Daperno
Milan Lukáš
Alessandro Armuzzi
Mark Löwenberg
Daniel R Gaya
Laurent Peyrin-Biroulet
Rodolfo Rocca
Susana Lopes
Flavio Caprioli
Sandro Ardizzone
Ana Echarri Piudo
Paolo Gionchetti
Xavier Roblin
Ursula Seidler
David Andersson
Kamal Patel
Pierre Desreumaux
Simone Saibeni
Gustav From
Miroslav Fedurco
Milos Gregus
Yoram Bouhnik
Andreas Luegering
Rocco Cosintino
Ivan Bunganic
Jaime Ramos
Mariam Aguas Peris
Olivier Dewit
Mariabeatrice Principi
Emma Wesley
Paula Lago
Stephane Nancey
María Dolores Martín Arranz
Pieter Hindryckx
Ambrogio Orlando
Andrea Geccherle
Maria Laura Annunziata
Bu'hussain Hayee
Jozef Balaz
Francisco Portela
Cyrielle Gilletta
Torsten Kucharzik
Miguel Mínguez
Javier Pérez Gisbert
Ana Gutiérrez Casbas
Edouard Louis
Marco Marino
Gareth Parkes
Fraser Cummings
Bindia Jharap
Jens Kjeldsen
Luís Correia
Paula Ministro
Matthias Ebert
Erik Hertervig
Dirk Staessen
Joris Dutré
Arnaud Colard
Graham Morrison
Henning Glerup
Jens Frederik Dahlerup
Frank Wolfhagen
Marian Batovsky
Martin Molnar
Barbora Kadleckova
Paulo Caldeira
David Laharie
Xavier Hebuterne
Bruno Bonaz
Matthieu Allez
Andreas Fischer
Joaquín Ernesto Hinojosa Del Val
Miriam Mañosa Ciria
Jose Manuel Herrera Justiniano
Charlotte Soderman
Rajiv Chandy
Craig Mowat
Peter Irving
Jan Fallingborg
Jan Matous
Tomas Douda
Romain Altwegg
Jose Manuel Benitez
María Teresa Arroyo Villarino
Jordi Guardiola Capón
Daniel Ginard Vicenc
Pieter Dewint
Sven Almer
Sebastien Kindt

収録刊行物

The Lancet Gastroenterology & Hepatology

The Lancet Gastroenterology & Hepatology 7 (4), 294-306, 2022-04

Elsevier BV

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

収録刊行物

被引用文献 (1)*注記

詳細情報詳細情報について

書き出し

問題の指摘

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

収録刊行物

被引用文献 (1)*注記

詳細情報 詳細情報について

書き出し

問題の指摘

参加プロジェクトリスト

詳細情報詳細情報について